SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-20-094778
Filing Date
2020-08-13
Accepted
2020-08-13 17:26:14
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 a20-27412_1424b5.htm 424B5 451913
2 GRAPHIC g274121cai001.gif GRAPHIC 7254
3 GRAPHIC g274121aai001.gif GRAPHIC 7268
4 GRAPHIC g274121bci001.jpg GRAPHIC 4187
5 GRAPHIC g274121bci002.jpg GRAPHIC 20667
  Complete submission text file 0001104659-20-094778.txt   507696
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-237163 | Film No.: 201100361
SIC: 2834 Pharmaceutical Preparations